Disclosures for "A Proof-of-concept Study of TR-012001, a Nasal Levodopa, in Patients with Parkinson’s Disease with OFF Episodes, Without Dopa Decarboxylase Inhibitor"
-
Prof. Nomoto has nothing to disclose.
-
Dr. Yabe has nothing to disclose.
-
Dr. Ando has nothing to disclose.
-
Mr. Sumiyoshi has received personal compensation for serving as an employee of Shin Nippon Biomedical Laboratories, Ltd., Japan. Mr. Sumiyoshi has received personal compensation for serving as an employee of SNLD, Ltd., Japan.
-
Dr. Akagi has received personal compensation for serving as an employee of SNLD, Ltd., Japan. Dr. Akagi has received personal compensation for serving as an employee of Shin Nippon Biomedical Laboratories, Ltd., Japan.
-
Dr. Ise has received personal compensation for serving as an employee of SNLD, Ltd., Japan. Dr. Ise has received personal compensation for serving as an employee of Shin Nippon Biomedical Laboratories, Ltd., Japan.
-
Dr. Akiyoshi has received personal compensation for serving as an employee of SNBL, Ltd.. Dr. Akiyoshi has received personal compensation for serving as an employee of Tour de Medication, Ltd.. Dr. Akiyoshi has stock in SNBL, Ltd..
-
Ms. Date has received personal compensation for serving as an employee of SNLD, Ltd., Japan. Ms. Date has received personal compensation for serving as an employee of Shin NIppon Biomedical Laboratories, Ltd., Japan.
-
Mr. Nakano has received personal compensation for serving as an employee of SNLD, Ltd., Japan. Mr. Nakano has received personal compensation for serving as an employee of Shin Nippon Biomedical Laboratories, Ltd., Japan.
-
Mr. Suzuki has received personal compensation for serving as an employee of SNLD, Ltd., Japan. Mr. Suzuki has received personal compensation for serving as an employee of Shin Nippon Biomedical Laboratories, Ltd., Japan.